Stem Cell Therapeutic and Research Reauthorization Act of 2025
Description
Stem Cell Therapeutic and Research Reauthorization Act of 2025
Stem Cell Therapeutic and Research Reauthorization Act of 2025
Mr. Guthrie moved to suspend the rules and pass the bill, as amended.
Jul 20, 2026
Considered under suspension of the rules. (consideration: CR H4642-4643)
Jul 20, 2026
DEBATE - The House proceeded with forty minutes of debate on H.R. 5160.
Jul 20, 2026
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H4642)
Jul 20, 2026
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H4642)
Jul 20, 2026
Motion to reconsider laid on the table Agreed to without objection.
Jul 20, 2026
Stem Cell Therapeutic and Research Reauthorization Act of 2025, as amended
Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 464.
Jul 21, 2026